NATURES SUNSHINE PRODUCTS INC

NATR

NATURES SUNSHINE PRODUCTS INC

NATR

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-12Shares Purchased (TTM):0Shares Sold (TTM):98,651

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:14,300,647Shares Outstanding:17,522,000Institutional Ownership Pct.:81.62%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	83	88	94	96	81	86	85	79	69	78	82	76
Accounts Receivable Net Current	14	13	9	15	13	11	9	11	11	10	9	9
Inventory Net	72	67	68	67	69	65	59	62	62	63	67	66
Prepaid Expense And Other Assets Current	10	11	8	8	8	8	7	11	10	10	8	8
Assets Current	178	179	179	186	172	171	161	164	152	160	166	160
Property Plant And Equipment Net	31	31	33	34	36	38	40	42	45	45	45	46
Operating Lease Right Of Use Asset	19	20	18	13	14	13	13	14	14	16	13	14
Debt Securities Trading Restricted	1	1	1	1	1	1	1	1	1	1	1	1
Deferred Income Tax Assets Net	19	19	20	20	21	20	18	15	15	15	15	9
Other Assets Noncurrent	10	10	11	10	10	10	9	10	10	10	10	9
Assets	260	261	261	265	255	253	241	245	236	247	250	240
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	8	8	8	7	10	10	9	9	8	9	8	7
Accrued Liabilities Current	26	25	34	31	27	25	25	24	23	23	33	32
Contract With Customer Liability Current	2	3	6	8	6	2	3	2	2	2	2	1
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	0	-
Accrued Income Taxes Current	3	5	5	8	6	7	4	7	4	7	6	5
Operating Lease Liability Current	4	4	3	5	5	4	4	4	4	5	5	5
Notes Payable Current	-	-	-	-	-	-	-	-	-	-	-	0
Liabilities Current	69	71	79	84	76	71	66	67	64	69	77	73
Liability For Uncertain Tax Positions Noncurrent	0	0	0	0	1	1	1	1	1	1	0	0
Operating Lease Liability Noncurrent	17	18	16	10	11	11	10	11	11	13	10	11
Long Term Debt	-	-	-	-	-	-	-	-	-	2	-	-
Deferred Compensation Liability Classified Noncurr…	1	1	1	1	1	1	1	1	1	1	1	1
Deferred Income Tax Liabilities Net	1	1	1	1	1	1	1	1	1	2	1	1
Other Liabilities Noncurrent	3	3	3	2	2	2	1	1	1	1	1	1
Liabilities	91	95	100	98	91	86	80	83	79	88	90	88
Stockholders Equity
Common Stock Value	101	102	102	104	105	115	115	114	114	119	120	123
Retained Earnings Accumulated Deficit	86	82	77	73	67	62	57	58	53	52	50	41
Minority Interest	-	-	0	6	6	6	6	6	6	6	5	5
Accumulated Other Comprehensive Income Loss Net Of…	-17	-17	-18	-16	-14	-16	-17	-15	-17	-17	-15	-17
Stockholders Equity	169	167	162	167	164	167	161	163	156	160	160	152
Liabilities And Stockholders Equity	260	261	261	265	255	253	241	245	236	247	250	240
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock No Par Value	0	0	-	0	0	0	-	0	0	0	-	0
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Shares Outstanding	18	18	18	18	18	18	18	18	19	19	19	19
Common Stock Shares Issued	18	18	18	18	18	18	18	18	19	19	19	19

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-13.32%	-14.38%	-16.90%	-	-	-	-	-	-	-	-	-
2025	24.58%	16.84%	18.53%	17.06%	15.42%	1.21%	49.89%	57.39%	79.68%	-3.31%	6.30%	-15.15%
2024	-19.87%	-21.18%	-11.24%	-5.87%	-4.23%	-11.66%	17.17%	8.37%	4.18%	-18.76%	-13.86%	6.62%
2023	-	-	-	18.38%	17.60%	22.85%	-4.55%	-5.31%	-0.05%	14.77%	10.81%	-10.93%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.60	2.50	2.28	2.22	2.27	2.41	2.44	2.44	2.39	2.33	2.16	2.19
Quick Ratio	1.40	1.40	1.31	1.32	1.24	1.38	1.43	1.34	1.26	1.27	1.19	1.17
Working Capital	109.65M	107.22M	100.31M	102.44M	95.98M	100.04M	94.89M	96.38M	88.39M	91.28M	89.06M	86.91M
Leverage & Debt
Debt to Equity	0.53	0.57	0.62	0.59	0.56	0.51	0.50	0.51	0.51	0.55	0.57	0.58
Interest Coverage TTM	207.96	251.04	252.48	315.41	266.84	139.63	137.64	150.73	189.57	1,933.42	-	-
Debt Ratio	0.35	0.36	0.38	0.37	0.36	0.34	0.33	0.34	0.34	0.35	0.36	0.37
Efficiency & Turnover
Asset Turnover TTM	1.91	1.91	1.91	1.86	1.88	1.83	1.85	1.83	1.87	1.86	1.86	1.90
Days Sales Outstanding TTM	9.97	8.93	6.87	10.20	9.63	8.44	7.35	8.56	9.82	8.22	9.40	8.09
Receivables Turnover TTM	36.60	40.88	53.12	35.80	37.90	43.27	49.65	42.62	37.18	44.39	38.84	45.11
Per Share Metrics
Diluted EPS TTM	1.02	1.15	1.11	0.83	0.75	0.54	0.40	0.94	0.85	0.91	0.84	0.45
Free Cash Flow Per Share TTM	1.02	1.31	1.60	1.77	1.21	0.94	0.77	0.69	0.79	1.18	1.61	1.21
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	73.16%	72.71%	72.42%	72.28%	71.77%	71.68%	71.46%	71.43%	71.87%	72.19%	72.11%	72.18%
Operating Profit Margin TTM	5.96%	5.74%	5.15%	5.05%	4.40%	4.74%	4.42%	4.77%	4.94%	5.18%	4.21%	3.92%
Net Profit Margin TTM	3.80%	4.22%	4.26%	3.16%	3.10%	2.25%	1.69%	4.00%	3.69%	3.91%	3.69%	2.00%
Growth Metrics
Net Revenue Growth (1Y)	6.77%	7.26%	5.67%	6.62%	4.33%	2.00%	2.03%	1.36%	2.14%	6.58%	5.55%	0.47%
Net Income Growth (1Y)	30.89%	101.63%	165.74%	-15.85%	-12.30%	-41.32%	-53.12%	103.14%	185.38%	392.65%	-4,309.23%	-15.50%
EPS Growth (1Y)	35.25%	112.72%	174.75%	-11.68%	-11.16%	-40.24%	-51.99%	109.95%	195.26%	398.74%	-4,366.63%	-15.21%
Valuation Metrics
P/E TTM	20.76	20.32	19.00	18.28	19.05	22.61	35.46	14.17	17.25	22.37	20.08	36.18
P/B TTM	2.29	2.52	2.41	1.64	1.66	1.39	1.70	1.55	1.80	2.45	2.07	2.09
P/S TTM	0.79	0.86	0.81	0.58	0.59	0.51	0.60	0.57	0.64	0.87	0.74	0.72
Market Cap	388.30M	420.35M	388.55M	273.74M	272.22M	232.00M	272.91M	252.13M	281.01M	391.06M	329.65M	317.03M
Enterprise Value	305.80M	332.77M	294.66M	178.19M	190.88M	145.51M	188.21M	173.43M	212.32M	315.39M	247.28M	241.21M
Calculated Values
Free Cash Flow TTM	18.09M	23.02M	28.84M	31.27M	22.36M	17.33M	14.33M	12.69M	14.69M	22.25M	30.75M	23.08M
Net Debt	-82.50M	-87.58M	-93.89M	-95.55M	-81.35M	-86.49M	-84.70M	-78.70M	-68.70M	-75.67M	-82.37M	-75.82M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-12Sale

Owner: Herbert, Kevin R.

Title: EVP & President, North America

Shares: 2,000

Price/Share: $20.69

Value: $41,380.00

Shares Owned: 48,866

Relationship: Officer

Ownership: Direct

2026-06-05Sale

Owner: Yates, Bryant J

Title: EVP & President, Europe

Shares: 11,968

Price/Share: $19.90

Value: $238,163.20

Shares Owned: 77,446

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Norman, Daniel C

Title: EVP & President, Asia

Shares: 9,713

Price/Share: $20.64

Value: $200,476.32

Shares Owned: 47,276

Relationship: Officer

Ownership: Direct

2026-05-21Sale

Owner: Brower, Nathan G

Title: EVP, General Counsel

Shares: 12,015

Price/Share: $21.84

Value: $262,407.60

Shares Owned: 43,438

Relationship: Officer

Ownership: Direct

2026-03-13Sale

Owner: Norman, Daniel C

Title: EVP & President, Asia

Shares: 15,383

Price/Share: $24.52

Value: $377,191.16

Shares Owned: 55,693

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Herbert, Kevin R.	Officer	EVP & President, North America	Direct	Sale	2,000	20.69	$41,380.00	48,866	4
2026-06-05	Yates, Bryant J	Officer	EVP & President, Europe	Direct	Sale	11,968	19.90	$238,163.20	77,446	4
2026-06-01	Norman, Daniel C	Officer	EVP & President, Asia	Direct	Sale	9,713	20.64	$200,476.32	47,276	4
2026-05-21	Brower, Nathan G	Officer	EVP, General Counsel	Direct	Sale	12,015	21.84	$262,407.60	43,438	4
2026-03-13	Norman, Daniel C	Officer	EVP & President, Asia	Direct	Sale	15,383	24.52	$377,191.16	55,693	4
2026-03-13	Yates, Bryant J	Officer	EVP & President, Europe	Direct	Sale	19,516	24.35	$475,214.60	85,154	4
2026-03-13	Lanoy, Jonathan David	Officer	SVP, Chief Accounting Officer	Direct	Sale	4,000	24.70	$98,800.00	46,405	4
2025-12-12	Yates, Bryant J	Officer	EVP & President, Europe	Direct	Sale	1,700	22.29	$37,893.00	98,604	4
2025-11-18	Lanoy, Jonathan David	Officer	SVP, Chief Accounting Officer	Direct	Sale	5,000	20.45	$102,250.00	46,233	4
2025-11-14	Brower, Nathan G	Officer	EVP, General Counsel	Direct	Sale	3,800	20.81	$79,078.00	46,735	4
2025-11-12	Norman, Daniel C	Officer	EVP & President, Asia	Direct	Sale	8,884	20.46	$181,766.64	66,636	4
2025-08-29	Yates, Bryant J	Officer	EVP & President, Europe	Direct	Sale	4,672	16.71	$78,069.12	97,498	4
2025-08-13	Lanoy, Jonathan David	Officer	SVP, Chief Accounting Officer	Direct	Sale	5,000	16.51	$82,550.00	50,051	4
2025-08-13	Brower, Nathan G	Officer	EVP, General Counsel	Direct	Sale	9,996	16.54	$165,333.84	48,277	4
2025-06-27	Fosun, Pharma Usa Inc., S…	TenPercentOwner	-	Indirect	Sale	2,854,607	11.46	$32,713,796.22	0	4
2024-10-15	Shanghai, Fosun Pharmaceu…	TenPercentOwner	-	Indirect	Sale	2,300	13.02	$29,946.00	64,167	4
2024-10-14	Shanghai, Fosun Pharmaceu…	TenPercentOwner	-	Indirect	Sale	1,300	13.12	$17,056.00	66,467	4
2024-06-06	Yates, Bryant J	Officer	EVP & President, Europe	Direct	Sale	3,068	15.30	$46,940.40	98,852	4
2023-11-30	Norman, Daniel C	Officer	EVP & President, Asia	Direct	Sale	13,000	17.06	$221,780.00	54,765	4
2023-11-21	Brower, Nathan G	Officer	EVP, General Counsel	Direct	Sale	3,999	17.31	$69,222.69	43,760	4
2023-08-29	Yates, Bryant J	Officer	EVP & President, Europe	Direct	Sale	15,000	16.77	$251,550.00	94,150	4
2023-08-28	Norman, Daniel C	Officer	EVP & President, Asia	Direct	Sale	12,036	16.40	$197,390.40	69,765	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

81.62%

Inst. Shares: 14,300,647

Shares Outstanding: 17,522,000

2025-12-31

75.99%

Inst. Shares: 13,682,446

Shares Outstanding: 18,005,000

2025-09-30

77.91%

Inst. Shares: 13,740,956

Shares Outstanding: 17,638,000

2025-06-30

73.34%

Inst. Shares: 13,498,123

Shares Outstanding: 18,406,000

2025-03-31

79.30%

Inst. Shares: 14,658,921

Shares Outstanding: 18,486,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	14,300,647	17,522,000	81.62%
2025-12-31	13,682,446	18,005,000	75.99%
2025-09-30	13,740,956	17,638,000	77.91%
2025-06-30	13,498,123	18,406,000	73.34%
2025-03-31	14,658,921	18,486,000	79.30%
2024-12-31	14,699,040	18,616,000	78.96%
2024-09-30	14,776,763	18,512,000	79.82%
2024-06-30	14,320,153	18,647,000	76.80%
2024-03-31	13,757,094	18,828,000	73.07%
2023-12-31	13,609,580	19,066,000	71.38%
2023-09-30	13,120,024	19,133,000	68.57%
2023-06-30	13,267,970	19,293,000	68.77%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NATURES SUNSHINE PRODUCTS INC (NATR) — SEC Financial Statements & Analysis

NATURES SUNSHINE PRODUCTS INC (NATR) is a pharmaceutical preparations company, incorporated in UT. NATURES SUNSHINE PRODUCTS INC trades on Nasdaq as: NATR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NATURES SUNSHINE PRODUCTS INC reported a 6.77% year-over-year revenue growth, a Gross Profit Margin of 73.16% (TTM), a Debt-to-Equity ratio of 0.53x, a Price-to-Sales (P/S) ratio of 0.79x (TTM), a Price-to-Book (P/B) ratio of 2.29x (TTM), at a market cap of $388.30M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.77%
Gross Profit Margin TTM: 73.16%
Debt To Equity: 0.53x
P/S TTM: 0.79x
P/B TTM: 2.29x
Market Cap: $388.30M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NATURES SUNSHINE PRODUCTS INC in?

NATURES SUNSHINE PRODUCTS INC (NATR) operates in the Pharmaceutical Preparations industry.

What is NATR's market cap?

NATURES SUNSHINE PRODUCTS INC (NATR) has a market capitalization of $388.30M as of 2026-06-30.

What is NATR's P/E ratio?

NATURES SUNSHINE PRODUCTS INC (NATR)'s trailing twelve month P/E ratio is 20.76x as of 2026-06-30.

What exchange does NATR trade on?

NATURES SUNSHINE PRODUCTS INC (NATR) trades on the Nasdaq.

Where is NATURES SUNSHINE PRODUCTS INC incorporated?

NATURES SUNSHINE PRODUCTS INC is incorporated in UT.